Search

Resneck, Jack S, Emily P Tierney, and Alexa Boer Kimball. 2006. “Challenges Facing Academic Dermatology: Survey Data on the Faculty Workforce.”. Journal of the American Academy of Dermatology 54 (2): 211-6.

Chang, Howard Y, Todd W Ridky, Alexandra B Kimball, Elizabeth Hughes, and Anthony E Oro. 2003. “Eruptive Xanthomas Associated With Olanzapine Use.”. Archives of Dermatology 139 (8): 1045-8.

Corey, Kristen C, Marisa Kardos Garshick, Voraphat Dejsuphong, Xinaida T Lima, and Alexandra B Kimball. 2012. “Skin Carotenoid Levels Are Not Associated With Risk of Nonmelanoma Skin Cancer: Response to ‘Supplement Use and the Risk of Cutaneous Squamous Cell Carcinoma’.”. Journal of the American Academy of Dermatology 67 (5): 1071-2; author reply 1073.

Chopra, Divya, Nimay Anand, Shandi Brito, Patricia M Coutts, Ralph George, Alexa B Kimball, Robert S Kirsner, Afsaneh Alavi, and Hadar Lev-Tov. 2023. “Wound Care for Patients With Hidradenitis Suppurativa: Recommendations of an International Panel of Experts.”. Journal of the American Academy of Dermatology 89 (6): 1289-92.

Kimball, Alexa B, Maurizio Podda, Afsaneh Alavi, Megan Miller, Yaung-Kaung Shen, Shu Li, Yan Xu, et al. 2023. “Guselkumab for the Treatment of Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Phase 2 Randomized Study.”. Journal of the European Academy of Dermatology and Venereology : JEADV 37 (10): 2098-2108.

Kim, Diana S, Nicole Giannotti, Prerna Salian, Alexa B Kimball, and Martina L Porter. 2022. “Travel Burden on Patients at a Subspecialty Hidradenitis Suppurativa Clinic: A Single-Center Retrospective Study.”. International Journal of Women’s Dermatology 8 (4): e027.

Hamaguchi, Ryoko, Taylor L Wearda, Angela S Volk, Kimberly M Kramer, Alexa B Kimball, Abigail E Chaffin, and Dennis P Orgill. 2022. “Surgical Management of Hidradenitis Suppurativa: A Two-Center Retrospective Study.”. Plastic and Reconstructive Surgery 150 (5): 1115-27.

Kimball, Alexa B, Christian Loesche, Errol P Prens, Falk G Bechara, Jamie Weisman, Izabela Rozenberg, Philip Jarvis, et al. 2022. “IL-17A Is a Pertinent Therapeutic Target for Moderate-to-Severe Hidradenitis Suppurativa: Combined Results from a Pre-Clinical and Phase II Proof-of-Concept Study.”. Experimental Dermatology 31 (10): 1522-32.

Ingram, J R, V Bettoli, J I Espy, G Kokolakis, A Martorell, A P Villani, H Wallinger, et al. 2022. “Unmet Clinical Needs and Burden of Disease in Hidradenitis Suppurativa: Real-World Experience from EU5 and US.”. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (9): 1597-1605.

Morss-Walton, Peyton C, Charlotte Greif, Zachary E Holcomb, Prerna Salian, Tuyen Yankama, Diana Kim, Martina L Porter, and Alexa B Kimball. 2022. “Treatment of Hidradenitis Suppurativa Resolves Associated Hematologic Abnormalities.”. International Journal of Women’s Dermatology 8 (1): e011.